Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients (Q42443957)

31 October 2017

Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients (English)

1 reference

31 October 2017

P Podevin

1

1 reference

31 October 2017

J Guechot

2

1 reference

31 October 2017

L Serfaty

3

1 reference

31 October 2017

L Monrand-Joubert

4

1 reference

31 October 2017

C Veyrunes

5

1 reference

31 October 2017

M T Bonnefis

6

1 reference

31 October 2017

R Poupon

7

1 reference

31 October 2017

language of work or name

1 reference

1 August 1997

1 reference

31 October 2017

Journal of Hepatology

1 reference

31 October 2017

27

1 reference

31 October 2017

2

1 reference

31 October 2017

265-271

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Positive and negative hepatitis C virus RNA strands in serum, liver and peripheral blood mononuclear cells in anti-HCV patients: relation with the liver lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

The antiviral activity of recombinant human tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Antiviral effects of recombinant tumour necrosis factor in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

The interferon-induced enzyme oligo-isoadenylate synthetase: Rapid determination of its in vitro products

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Severity of liver disease with different hepatitis C viral clones

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Changes of serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Hormonal and immunological regulation of 2', 5'-oligoadenylate synthetase activity in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Comparison of (2′-5′) Oligo-adenylate Synthetase and Interferon Blood-Levels in Mice Early After Viral Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Monitoring of Interferon Therapy by Assay of (2′-5′) Oligo-Isoadenylate Synthetase in Human Peripheral White Blood Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Hepatitis B virus suppresses expression of human beta-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Defective response to interferons in cells transfected with the hepatitis B virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Binding of Tat Protein to TAR Region of Human Immunodeficiency Virus Type 1 Blocks TAR-Mediated Activation of (2′-5′)Oligoadenylate Synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

HCV genotypes in chronic hepatitis C and response to interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Interaction of interferon-α with interleukin-1β or tumor necrosis factor-α on hepatitis B virus enhancer activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Impaired lipopolysaccharide-induced interleukin-1-beta production in patients with anti-hepatitis C virus antibody-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

Impaired lipopolysaccharide-inducible tumor necrosis factor production in vitro by peripheral blood monocytes of patients with viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980170-5

7 January 2021

10.1016/S0168-8278(97)80170-5

Identifiers

DOI

1 reference

31 October 2017

1 reference